Fluoropharma Medical, Inc. (PN) Stock Price - FPMI

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Fluoropharma Medical, Inc. (PN) FPMI OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.00065 -12.38% 0.0046 0.0048 0.0046 0.0048 0.00525 17:00:09
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 31,000 $ 0.0048 $ 149 4,249 0.0011 - 0.20
Last Trade Time Type Quantity Stock Price Currency
09:48:20 25,000 $ 0.0046 USD

Fluoropharma Medical, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 158.66k 34.49M $ -5.61M - - 21.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Fluoropharma Medical, Inc. (PN) News

Loading Messages....

Latest FPMI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPMI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00350.00890.00350.00853530,0000.001131.43%
1 Month0.0180.0180.00110.010864218,068-0.0134-74.44%
3 Months0.0160.01870.00110.011854721,552-0.0114-71.25%
6 Months0.06570.070.00110.023241155,334-0.0611-93.0%
1 Year0.07450.200.00110.045887135,829-0.0699-93.83%
3 Years0.1850.250.00110.07200140,744-0.1804-97.51%
5 Years0.44010.550.00110.200817842,292-0.4355-98.95%

Fluoropharma Medical, Inc. (PN) Description

We are a molecular imaging company headquartered in Montclair, NJ. The Company was founded to engage in the discovery, development and commercialization of proprietary products for the positron emission tomography (PET) market. The Company's initial focus has been on the development of novel cardiovascular imaging agents that can more efficiently and effectively detect and assess acute and chronic forms of coronary artery disease (CAD). Molecular imaging pharmaceuticals are radiopharmaceuticals that enable early detection of disease through the visualization of subtle changes in biochemical and biological processes.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.